These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 11057853)

  • 21. Factor V Leiden (Arg506Gln), a confounding genetic risk factor but not mandatory for the occurrence of venous thromboembolism in homozygotes and obligate heterozygotes for cystathionine beta-synthase deficiency.
    Yap S; O'Donnell KA; O'Neill C; Mayne PD; Thornton P; Naughten E
    Thromb Haemost; 1999 Apr; 81(4):502-5. PubMed ID: 10235428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genetic polymorphisms of homocysteine metabolism related enzymes in patients with coronary heart disease].
    Xu H; Chen Z; Tang J
    Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):414-6. PubMed ID: 11715433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion.
    Marcucci R; Giusti B; Betti I; Evangelisti L; Fedi S; Sodi A; Cappelli S; Menchini U; Abbate R; Prisco D
    Thromb Res; 2003 Apr; 110(1):7-12. PubMed ID: 12877902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperhomocysteinemia and the compound heterozygous state for methylene tetrahydrofolate reductase are independent risk factors for deep vein thrombosis among South Indians.
    Naushad S; Jamal NJ; Angalena R; Prasad CK; Devi AR
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):113-7. PubMed ID: 17287626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
    Hermans MP; Gala JL; Buysschaert M
    Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis.
    Di Minno MN; Pezzullo S; Palmieri V; Coppola A; D'Angelo A; Sampietro F; Cavalca V; Tremoli E; Di Minno G
    Thromb Res; 2011 Oct; 128(4):e43-8. PubMed ID: 21669453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genotypes and haplotypes and plasma homocysteine levels in patients with occlusive artery disease and deep venous thrombosis.
    Spiroski I; Kedev S; Antov S; Arsov T; Krstevska M; Dzhekova-Stojkova S; Bosilkova G; Kostovska S; Trajkov D; Petlichkovski A; Strezova A; Efinska-Mladenovska O; Spiroski M
    Acta Biochim Pol; 2008; 55(3):587-94. PubMed ID: 18800176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation analysis between plasma homocysteine level and polymorphism of homocysteine metabolism related enzymes in ischemic cerebrovascular or cardiovascular diseases].
    Zhang G; Dai C
    Zhonghua Xue Ye Xue Za Zhi; 2002 Mar; 23(3):126-9. PubMed ID: 12015064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population.
    Richter B; Stegmann K; Röper B; Böddeker I; Ngo ET; Koch MC
    J Hum Genet; 2001; 46(3):105-9. PubMed ID: 11310576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mutation Ala677-->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis.
    Arruda VR; von Zuben PM; Chiaparini LC; Annichino-Bizzacchi JM; Costa FF
    Thromb Haemost; 1997 May; 77(5):818-21. PubMed ID: 9184384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases.
    Zhang G; Dai C
    Thromb Res; 2001 Nov; 104(3):187-95. PubMed ID: 11672761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and biochemical investigations of patients with intermediate or severe hyperhomocysteinemia.
    Sørensen JT; Gaustadnes M; Stabler SP; Allen RH; Mudd SH; Hvas AM
    Mol Genet Metab; 2016 Mar; 117(3):344-50. PubMed ID: 26750749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphism.
    Gonzalez-Porras JR; Martin-Herrero F; Garcia-Sanz R; Lopez ML; Balanzategui A; Mateos MV; Pavon P; Gonzalez M; Alberca I; San Miguel JF
    Thromb Res; 2007; 119(6):691-8. PubMed ID: 17005242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
    Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
    Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mild hyperhomocysteinemia and low folate concentrations as risk factors for cervical arterial dissection.
    Arauz A; Hoyos L; Cantú C; Jara A; Martínez L; García I; Fernández Mde L; Alonso E
    Cerebrovasc Dis; 2007; 24(2-3):210-4. PubMed ID: 17596690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 677TT polymorphism of methylenetetrahydrofolate reductase in combination with low serum vitamin B12 is associated with coronary in-stent restenosis.
    Chung SL; Chiou KR; Charng MJ
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):349-55. PubMed ID: 16489563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis.
    Pathare A; al Kindi S; al Belushi T; Bayoumi R; Dennison D; Murlitharan S
    Haematologia (Budap); 2002; 32(4):551-6. PubMed ID: 12803132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic susceptibility to preeclampsia: roles of cytosineto-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor V Leiden mutation.
    Kim YJ; Williamson RA; Murray JC; Andrews J; Pietscher JJ; Peraud PJ; Merrill DC
    Am J Obstet Gynecol; 2001 May; 184(6):1211-7. PubMed ID: 11349190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hyperhomocysteinemia and deep-vein thrombosis].
    Qiu L; Yan SK; Song YH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):706-9. PubMed ID: 14714317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions among methylenetetrahydrofolate reductase (MTHFR) and cystathionine β-synthase (CBS) polymorphisms - a cross-sectional study: multiple heterozygosis as a risk factor for higher homocysteine levels and vaso-occlusive episodes.
    Amaral FM; Miranda-Vilela AL; Lordelo GS; Ribeiro IF; Daldegan MB; Grisolia CK
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.